A detailed history of Toroso Investments, LLC transactions in Viatris Inc stock. As of the latest transaction made, Toroso Investments, LLC holds 64,067 shares of VTRS stock, worth $681,032. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,067
Previous 61,100 4.86%
Holding current value
$681,032
Previous $661,000 15.58%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $33,438 - $40,143
2,967 Added 4.86%
64,067 $764,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $229,923 - $284,454
-26,217 Reduced 30.03%
61,100 $661,000
Q3 2023

Nov 15, 2023

BUY
$9.59 - $11.35 $273,813 - $324,065
28,552 Added 48.59%
87,317 $860,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $173,833 - $198,308
-19,272 Reduced 24.7%
58,765 $586,000
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $86,158 - $114,814
9,365 Added 13.64%
78,037 $751,000
Q4 2022

Feb 15, 2023

BUY
$8.72 - $11.56 $10,324 - $13,687
1,184 Added 1.75%
68,672 $764,000
Q3 2022

Nov 23, 2022

BUY
$8.48 - $11.13 $122,739 - $161,095
14,474 Added 27.3%
67,488 $575,000
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $243,128 - $299,817
24,435 Added 85.5%
53,014 $555,000
Q1 2022

May 20, 2022

BUY
$9.81 - $15.4 $21,876 - $34,342
2,230 Added 8.46%
28,579 $311,000
Q4 2021

Feb 16, 2022

BUY
$12.09 - $14.68 $31,155 - $37,830
2,577 Added 10.84%
26,349 $356,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $15,012 - $17,142
1,133 Added 5.0%
23,772 $322,000
Q2 2021

Aug 13, 2021

BUY
$12.97 - $16.15 $15,654 - $19,493
1,207 Added 5.63%
22,639 $324,000
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $291,260 - $397,349
21,432 New
21,432 $299,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.